KOSDAQ - Delayed Quote KRW
OliX Pharmaceuticals, Inc (226950.KQ)
52,000.00
+1,100.00
+(2.16%)
At close: 3:30:15 PM GMT+9
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
71,249,226.32
102,825,049.70
132,651,479.85
86,671,974.33
Total Liabilities Net Minority Interest
52,776,577.15
52,489,094.57
66,448,925.30
67,264,591.99
Total Equity Gross Minority Interest
18,472,649.17
50,335,955.13
66,202,554.54
19,407,382.34
Total Capitalization
39,277,289.85
85,216,144.61
85,907,391.78
38,521,114.31
Preferred Stock Equity
--
436,856
1,500,004
--
Common Stock Equity
17,848,889.85
49,417,651.61
64,407,387.78
18,521,114.31
Capital Lease Obligations
751,238
3,995,709
4,765,689
539,486
Net Tangible Assets
16,143,744.61
47,873,883.78
63,799,963.51
16,386,742.95
Working Capital
-14,526,277.89
25,578,433.79
25,502,352.08
11,874,409.88
Invested Capital
56,290,073.85
84,779,288.61
103,637,700.81
54,926,431.53
Tangible Book Value
16,143,744.61
47,437,027.78
62,299,959.51
16,386,742.95
Total Debt
39,192,422
39,357,346
43,996,002.03
36,944,803.22
Net Debt
34,557,794
23,378,875
34,300,045.18
2,068,581.22
Share Issued
17,238.22
16,019.76
13,703.16
13,703.16
Ordinary Shares Number
17,238.22
16,019.76
13,703.16
13,703.16
Preferred Shares Number
--
873.71
3,000.01
--
12/31/2021 - 7/18/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade